0001127602-17-004564.txt : 20170208
0001127602-17-004564.hdr.sgml : 20170208
20170208155330
ACCESSION NUMBER: 0001127602-17-004564
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170207
FILED AS OF DATE: 20170208
DATE AS OF CHANGE: 20170208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edge Therapeutics, Inc.
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leuthner Brian A
CENTRAL INDEX KEY: 0001652973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 17582453
MAIL ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1600
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-02-07
0001472091
Edge Therapeutics, Inc.
EDGE
0001652973
Leuthner Brian A
300 CONNELL DRIVE,
SUITE 4000
BERKELEY HEIGHTS
NJ
07922
1
1
President and CEO
Common Stock
2017-02-07
4
S
0
1500
9.52
D
245479
D
Common Stock
275479
I
By Spouse
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $9.37 to $9.62 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Brian A. Leuthner by Albert N. Marchio II, attorney-in-fact
2017-02-08